Clearmind Medicine Inc. (CMND) stock
CMNDNasdaqPharmaceutical PreparationsFiscal year ends October 31
Financials through Q3 FY2026, quarter ended Jul 31, 2026Score 5/30
$4.62−0.33 (-6.67%)
Close on Nov 12, 2026Market cap $730.31KP/E –Yield –
Clearmind Medicine total assets
Total assets on the balance sheet at the end of each period.
Clearmind Medicine's total assets was $16.91M at Jul 31, 2026. For fiscal 2025 it was $6.08M, down 16.2% from the year before.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $6.08M | -16.2% |
| FY2024 | Oct 31, 2024 | $7.26M | +21.9% |
| FY2023 | Oct 31, 2023 | $5.95M | +620.4% |
| FY2022 | Oct 31, 2022 | $826.42K | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jul 31, 2026 | $16.91M | +326.0% |
| Q2 FY2026CQ1 2026 | Apr 30, 2026 | $14.52M | +180.4% |
| Q1 FY2026CQ4 2025 | Jan 31, 2026 | $11.14M | +69.2% |
| Q4 FY2025CQ3 2025 | Oct 31, 2025 | $6.08M | -16.2% |
| Q3 FY2025CQ2 2025 | Jul 31, 2025 | $3.97M | -51.4% |
| Q2 FY2025CQ1 2025 | Apr 30, 2025 | $5.18M | -41.4% |
| Q1 FY2025CQ4 2024 | Jan 31, 2025 | $6.58M | -34.8% |
| Q4 FY2024CQ3 2024 | Oct 31, 2024 | $7.26M | +21.9% |
| Q3 FY2024CQ2 2024 | Jul 31, 2024 | $8.17M | +889.0% |
| Q2 FY2024CQ1 2024 | Apr 30, 2024 | $8.85M | – |
| Q1 FY2024CQ4 2023 | Jan 31, 2024 | $10.10M | – |
| Q4 FY2023CQ3 2023 | Oct 31, 2023 | $5.95M | – |
| Q4 FY2022CQ3 2022 | Oct 31, 2022 | $826.42K | – |
See a number that looks wrong?